Background: Guidelines for blood products transfusion are needed to avoid unnecessary blood transfusion in acute and chronic anaemias to minimize complications.Objective: To evaluate the practice of blood transfusion in Baghdad Teaching Hospital.Patients and methods: One hundred and sixty adults Iraqi patients, who had blood transfusion, were selected randomly from different wards of Baghdad Teaching Hospital including General Medicine (GM), General Surgery (GS), Gynecology/Obstetrics (G/O), forty patients from each ward, from October 2011 to October 2012. Collected data included age, gender, type of ward, indication for transfusion, pre-transfusion packed cell volume (PCV) and hemoglobin (Hb), type (whole blood or red blood cells (RBCs)) and number of units transfused.Results: Pre-transfusion PCV was >30% (Hb >10gm/dl) in 23.1% of the patients, and were highest in G/O (47.5%) and GS (37.5%) wards. Whole blood was given instead of RBCs to 60% of patients (100% in G/O and GS).Single unit blood was given to 22.5% of patients (37.5% in G/O and 35% 1n GS.Conclusion: There is general unawareness of the risks of blood transfusion in Baghdad Teaching Hospital as shown by the use of whole blood instead of RBCs and single unit transfusion, so a more restrictive strategy is needed by following the international guidelines.
Background: Guidelines for blood products transfusion are needed to avoid unnecessary blood transfusion in acute and chronic anaemias to minimize complications.Objective: To evaluate the practice of blood transfusion in Baghdad Teaching Hospital.Patients and methods: One hundred and sixty adults Iraqi patients, who had blood transfusion, were selected randomly from different wards of Baghdad Teaching Hospital including General Medicine (GM), General Surgery (GS), Gynecology/Obstetrics (G/O), forty patients from each ward, from October 2011 to October 2012. Collected data included age, gender, type of ward, indication for transfusion, pre-transfusion packed cell volume (PCV) and hemoglobin (Hb), type (whole blood or red blood cells (RBCs)) and number of units transfused.Results: Pre-transfusion PCV was >30% (Hb >10gm/dl) in 23.1% of the patients, and were highest in G/O (47.5%) and GS (37.5%) wards. Whole blood was given instead of RBCs to 60% of patients (100% in G/O and GS).Single unit blood was given to 22.5% of patients (37.5% in G/O and 35% 1n GS.Conclusion: There is general unawareness of the risks of blood transfusion in Baghdad Teaching Hospital as shown by the use of whole blood instead of RBCs and single unit transfusion, so a more restrictive strategy is needed by following the international guidelines
Background: Cerebral ischemia associated with Antiphospholipid Syndrome(APS) is a common arterial manifestation in adults.Objectives: To look for the frequency of Antiphospholipid Antibodies (aPL), and their relation with other risk factors in young patients with cerebral ischemia.Patients and methods: A retrospective study of 40 young patient’s ≤ 50 years with stroke collected from medical and neurological wards of Baghdad Teaching Hospital (BTH) from January - December 2009. All were inquired about the presence of risk factors of stroke, and sent for aPL including Anticardiolipin (ACL) and Lupus Anticoagulant (LA).Results: Eight (20%) had ACL. Nine (22.5%) had LA. Both were present in 6(15%). ACL and/or LA were present in 11 (27.5%). Thirty three (82.5) patients had at least one risk factor, 8 of them had aPL, while 7(17.5%) had no risk factor and only 3 of them had aPL (p 0.1806).Conclusion: Antiphospholipid Syndrome is a possible risk factor of stroke and any young patient with stroke should be screened for aPL .
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.